MRI Safe Cardiac Resynchronisation Therapy Devices Market

Request Methodology

MRI-Safe CRT Devices Market Outlook (2022 to 2032)

The MRI-safe CRT devices market, which is valued at US$ 550.5 million as of 2022, is anticipated to be valued at US$ 1511 million by 2032 and is expected to grow at a CAGR of 9.6% during the forecast period.

Increasing cases of heart failure leading to increased hospitalization cases along with many other factors are expected to increase the demand for MRI-safe CRT devices.

Report Attribute	Details
MRI-Safe CRT Devices Market Valuation as on 2022	US$ 550.5 million
MRI-Safe CRT Devices Market Anticipated Value (2032)	US$ 1511 million
MRI-Safe CRT Devices Market Anticipated Growth Rate	9.6%

The MRI-safe CRT devices are primarily used to improve the heart’s efficiency by improving the oxygen and blood flow rate in the body.

The sales of MRI-safe CRT devices are expected to surge as these help patients who suffer from heart disease syndromes like shortness of breath, arrhythmia, fatigue, depression, or related symptoms.

Even the statistics suggest that the demand for MRI-safe CRT devices is expected to surge. Previously, the CAGR for the market was 7.8%. But, with the increasing usage, the anticipated CAGR has risen to 9.6%.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Current Market Dynamics pertaining to MRI-Safe CRT Devices Market?

The MRI-safe CRT devices have the ability to treat moderate to severe symptoms associated with heart failure. This kind of flexibility provided by these devices is expected to increase the MRI-safe CRT devices market size.

These devices are pocket-sized pacemakers, which are implanted just below the collarbone. This allows the patients to move around normally. Apart from that, these devices also detect heart rate abnormalities, as a result of which they transmit small pulses to synchronize the heart’s ventricles. This is expected to increase MRI-safe CRT device's market share.

A rapid increase in urbanization and improvement in healthcare infrastructure has also led to the penetration of hospitals in many parts of the world. This is expected to increase the sales of MRI-safe CRT devices. The increased urbanization has also led to an increase in disposable income, which makes MRI-safe CRT devices relatively affordable.

A number of studies have even suggested that the application of MRI-safe CRT devices has reduced the hospitalization case as well as the morbidity rate and has gradually led to an improvement in the patient’s health. This is expected to boom the demand for MRI-safe CRT devices.

There are a number of awareness programs on cardiovascular health being conducted by health regulatory bodies and governments across the world. This as well is expected to increase the sales of MRI-safe CRT devices. However, there are a few challenges that are being encountered by the MRI-safe CRT devices market. One of them is the scarcity of skilled professionals in the market.

The cost associated with these devices is also a factor that is acting as a barrier to market growth. Though there has been an increase in disposable income, not everybody can afford to buy this device.

One of the most critical barriers to the growth of the MRI-safe CRT devices market is the infection at the surgical site or the sensitivity to the device material. This is something that health professionals should take into consideration and come up with a suitable alternative.

Regional Analysis

How is the Performance of the North American MRI-Safe CRT Devices Market?

North America is currently the largest market for MRI-safe CRT devices and currently has a market share of 39.9%, and during the forecast period as well, it is expected to grow at a higher rate.

One of the major drivers of MRI-safe CRT devices in this region is the rate at which heart-based ailments are increasing amongst the masses in this region. Moreover, rapid advancements in the field of healthcare, along with relatively high disposable income, are expected to surge the adoption of MRI-safe CRT devices in North America.

How is the Performance of the European MRI-Safe CRT Devices Market?

Europe, which currently has a market share of 30%, is the second largest market for MRI-safe CRT devices and, during the forecast period as well, is estimated to be one of the most significant markets.

Apart from the disposable income and rapid developments in the field of healthcare, the healthcare authorities and the governments are actively spreading awareness regarding the benefits of MRI-safe CRT devices and sound cardiovascular health as well.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

How is the Start up Ecosystem in the MRI-Safe CRT Devices Market?

With a rise in heart-based ailments and even the authorities participating proactively to spread awareness regarding the same, the start-up ecosystem of the MRI-safe CRT devices market is looking for ways to provide a simple and effective solution to counter heart ailments.

One of the start-ups which are literally working towards creating an effective CRT device is ‘Cardiac Dimensions’. The Percutaneous mitral annuloplasty device leaves free access to cardiac veins for resynchronization therapy. This start-up has made it possible to implant the Carillon device prior to the CRT device in HF patients with low ejection fraction, wide QRS, and FMR.

Who are Some of the Key Market Players in the MRI-Safe CRT Devices Market?

Some of the key players in the MRI-safe CRT devices market are St. Jude Medical, Abbott, Medtronic, Boston Scientific Corporation, Cook Group, Scranton Gillette Communications, Philips, LivaNova, MicroPort Scientific, BIOTRONIK, Medico, and Qinming Medical.

The key players are now developing CRT devices in such a manner that the patients will be able to track their heart rates through smartphone connectivity and connected applications. This move is expected to make the tracking process simpler.

In June 2022, Abbott’s FreeStyle Libre 3 was named as CES 2022 Best of Innovation award winner. The other honourees include Libre Sense, Ultron 1.0 Software, the paired BinaxNOW covid-19 self-tests and NAVICA app, and the i-STAT TBI plasma test.
In March 2022, BIOTRONIK announced the introduction of a new mobile app update for cardiac device patients which is designed to exchange with clinical staff and better engage patients in their care.

Report Scope

Report Attribute	Details
Growth Rate	CAGR of 9.6% from 2022 to 2032
Base Year for Estimation	2021
Historical Data	2016 to 2021
Forecast Period	2022 to 2032
Quantitative Units	Revenue in USD Million and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered	Product Type Age Group Indication Region
Regions Covered	North America Latin America Europe East Asia South Asia Oceania Middle East and Africa
Key Countries Profiled	United States of America Canada Brazil Argentina Germany United Kingdom France Spain Italy Nordics BENELUX Australia & New Zealand China India ASIAN GCC Countries South Africa
Key Companies Profiled	St. Jude Medical Abbott Medtronic Boston Scientific Corporation Cook Group, Scranton Gillette Communications Philips LivaNova MicroPort Scientific BIOTRONIK Medico Qinming Medical
Customization	Available Upon Request

Key Segments Profiled in the MRI-Safe CRT Devices Market Survey

By Product Type:

Defibrillator
Pacemaker

By Age Group:

Paediatric
Geriatric

By Indication:

Cardiomyopathy
Bradycardia
Electrocardiography
Congestive Heart Failure

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

Frequently Asked Questions

What is the Growth Outlook for the MRI-Safe CRT Devices Market?

The MRI-safe CRT devices market is projected to grow at a CAGR of 9.6% during the forecast period.

What is the Valuation of MRI-Safe CRT Devices Market as on 2022?

The MRI-safe CRT devices market has a valuation of US$ 550.5 million as on 2022.

What is the Expected Valuation of MRI-Safe CRT Devices Market in 2032?

The MRI-safe CRT devices market is expected to be valued US$ 1511 million in 2032.

Table of Content

1. Executive Summary | MRI-Safe CRT Devices Market

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porter’s Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032

4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021

4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2021

5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032

5.3.1. Defibrillator

5.3.2. Pacemaker

5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2021

5.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032

6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Age Group

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Million) Analysis By Age Group, 2017 to 2021

6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Age Group, 2022 to 2032

6.3.1. Paediatric

6.3.2. Geriatric

6.4. Y-o-Y Growth Trend Analysis By Age Group, 2017 to 2021

6.5. Absolute $ Opportunity Analysis By Age Group, 2022 to 2032

7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Indication

7.1. Introduction / Key Findings

7.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2017 to 2021

7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2022 to 2032

7.3.1. Cardiomyopathy

7.3.2. Bradycardia

7.3.3. Electrocardiography

7.3.4. Congestive Heart Failure

7.4. Y-o-Y Growth Trend Analysis By Indication, 2017 to 2021

7.5. Absolute $ Opportunity Analysis By Indication, 2022 to 2032

8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region

8.1. Introduction

8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021

8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032

8.3.1. North America

8.3.2. Latin America

8.3.3. Europe

8.3.4. Asia Pacific

8.3.5. Middle East and Africa

8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

9.2.1. By Country

9.2.1.1. United States of America

9.2.1.2. Canada

9.2.2. By Product Type

9.2.3. By Age Group

9.2.4. By Indication

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Product Type

9.3.3. By Age Group

9.3.4. By Indication

9.4. Key Takeaways

10. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

10.2.1. By Country

10.2.1.1. Brazil

10.2.1.2. Mexico

10.2.1.3. Rest of Latin America

10.2.2. By Product Type

10.2.3. By Age Group

10.2.4. By Indication

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Product Type

10.3.3. By Age Group

10.3.4. By Indication

10.4. Key Takeaways

11. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

11.2.1. By Country

11.2.1.1. Germany

11.2.1.2. United Kingdom

11.2.1.3. France

11.2.1.4. Spain

11.2.1.5. Italy

11.2.1.6. Rest of Europe

11.2.2. By Product Type

11.2.3. By Age Group

11.2.4. By Indication

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Product Type

11.3.3. By Age Group

11.3.4. By Indication

11.4. Key Takeaways

12. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

12.2.1. By Country

12.2.1.1. China

12.2.1.2. Japan

12.2.1.3. South Korea

12.2.1.4. India

12.2.1.5. Malaysia

12.2.1.6. Singapore

12.2.1.7. Australia

12.2.1.8. New Zealand

12.2.1.9. Rest of Asia-Pacific

12.2.2. By Product Type

12.2.3. By Age Group

12.2.4. By Indication

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Product Type

12.3.3. By Age Group

12.3.4. By Indication

12.4. Key Takeaways

13. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

13.2.1. By Country

13.2.1.1. GCC Countries

13.2.1.2. South Africa

13.2.1.3. Israel

13.2.1.4. Rest of Middle East and Africa

13.2.2. By Product Type

13.2.3. By Age Group

13.2.4. By Indication

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Product Type

13.3.3. By Age Group

13.3.4. By Indication

13.4. Key Takeaways

14. Key Countries Market Analysis

14.1. United States of America

14.1.1. Pricing Analysis

14.1.2. Market Share Analysis, 2021

14.1.2.1. By Product Type

14.1.2.2. By Age Group

14.1.2.3. By Indication

14.2. Canada

14.2.1. Pricing Analysis

14.2.2. Market Share Analysis, 2021

14.2.2.1. By Product Type

14.2.2.2. By Age Group

14.2.2.3. By Indication

14.3. Brazil

14.3.1. Pricing Analysis

14.3.2. Market Share Analysis, 2021

14.3.2.1. By Product Type

14.3.2.2. By Age Group

14.3.2.3. By Indication

14.4. Mexico

14.4.1. Pricing Analysis

14.4.2. Market Share Analysis, 2021

14.4.2.1. By Product Type

14.4.2.2. By Age Group

14.4.2.3. By Indication

14.5. Germany

14.5.1. Pricing Analysis

14.5.2. Market Share Analysis, 2021

14.5.2.1. By Product Type

14.5.2.2. By Age Group

14.5.2.3. By Indication

14.6. United Kingdom

14.6.1. Pricing Analysis

14.6.2. Market Share Analysis, 2021

14.6.2.1. By Product Type

14.6.2.2. By Age Group

14.6.2.3. By Indication

14.7. France

14.7.1. Pricing Analysis

14.7.2. Market Share Analysis, 2021

14.7.2.1. By Product Type

14.7.2.2. By Age Group

14.7.2.3. By Indication

14.8. Spain

14.8.1. Pricing Analysis

14.8.2. Market Share Analysis, 2021

14.8.2.1. By Product Type

14.8.2.2. By Age Group

14.8.2.3. By Indication

14.9. Italy

14.9.1. Pricing Analysis

14.9.2. Market Share Analysis, 2021

14.9.2.1. By Product Type

14.9.2.2. By Age Group

14.9.2.3. By Indication

14.10. China

14.10.1. Pricing Analysis

14.10.2. Market Share Analysis, 2021

14.10.2.1. By Product Type

14.10.2.2. By Age Group

14.10.2.3. By Indication

14.11. Japan

14.11.1. Pricing Analysis

14.11.2. Market Share Analysis, 2021

14.11.2.1. By Product Type

14.11.2.2. By Age Group

14.11.2.3. By Indication

14.12. South Korea

14.12.1. Pricing Analysis

14.12.2. Market Share Analysis, 2021

14.12.2.1. By Product Type

14.12.2.2. By Age Group

14.12.2.3. By Indication

14.13. Malaysia

14.13.1. Pricing Analysis

14.13.2. Market Share Analysis, 2021

14.13.2.1. By Product Type

14.13.2.2. By Age Group

14.13.2.3. By Indication

14.14. Singapore

14.14.1. Pricing Analysis

14.14.2. Market Share Analysis, 2021

14.14.2.1. By Product Type

14.14.2.2. By Age Group

14.14.2.3. By Indication

14.15. Australia

14.15.1. Pricing Analysis

14.15.2. Market Share Analysis, 2021

14.15.2.1. By Product Type

14.15.2.2. By Age Group

14.15.2.3. By Indication

14.16. New Zealand

14.16.1. Pricing Analysis

14.16.2. Market Share Analysis, 2021

14.16.2.1. By Product Type

14.16.2.2. By Age Group

14.16.2.3. By Indication

14.17. GCC Countries

14.17.1. Pricing Analysis

14.17.2. Market Share Analysis, 2021

14.17.2.1. By Product Type

14.17.2.2. By Age Group

14.17.2.3. By Indication

14.18. South Africa

14.18.1. Pricing Analysis

14.18.2. Market Share Analysis, 2021

14.18.2.1. By Product Type

14.18.2.2. By Age Group

14.18.2.3. By Indication

14.19. Israel

14.19.1. Pricing Analysis

14.19.2. Market Share Analysis, 2021

14.19.2.1. By Product Type

14.19.2.2. By Age Group

14.19.2.3. By Indication

15. Market Structure Analysis

15.1. Competition Dashboard

15.2. Competition Benchmarking

15.3. Market Share Analysis of Top Players

15.3.1. By Regional

15.3.2. By Product Type

15.3.3. By Age Group

15.3.4. By Indication

16. Competition Analysis

16.1. Competition Deep Dive

16.1.1. Abbott

16.1.1.1. Overview

16.1.1.2. Product Portfolio

16.1.1.3. Profitability by Market Segments

16.1.1.4. Sales Footprint

16.1.1.5. Strategy Overview

16.1.1.5.1. Marketing Strategy

16.1.2. Medtronic

16.1.2.1. Overview

16.1.2.2. Product Portfolio

16.1.2.3. Profitability by Market Segments

16.1.2.4. Sales Footprint

16.1.2.5. Strategy Overview

16.1.2.5.1. Marketing Strategy

16.1.3. Boston Scientific

16.1.3.1. Overview

16.1.3.2. Product Portfolio

16.1.3.3. Profitability by Market Segments

16.1.3.4. Sales Footprint

16.1.3.5. Strategy Overview

16.1.3.5.1. Marketing Strategy

16.1.4. Cook Group

16.1.4.1. Overview

16.1.4.2. Product Portfolio

16.1.4.3. Profitability by Market Segments

16.1.4.4. Sales Footprint

16.1.4.5. Strategy Overview

16.1.4.5.1. Marketing Strategy

16.1.5. Philips

16.1.5.1. Overview

16.1.5.2. Product Portfolio

16.1.5.3. Profitability by Market Segments

16.1.5.4. Sales Footprint

16.1.5.5. Strategy Overview

16.1.5.5.1. Marketing Strategy

16.1.6. LivaNova

16.1.6.1. Overview

16.1.6.2. Product Portfolio

16.1.6.3. Profitability by Market Segments

16.1.6.4. Sales Footprint

16.1.6.5. Strategy Overview

16.1.6.5.1. Marketing Strategy

16.1.7. MicroPort Scientific

16.1.7.1. Overview

16.1.7.2. Product Portfolio

16.1.7.3. Profitability by Market Segments

16.1.7.4. Sales Footprint

16.1.7.5. Strategy Overview

16.1.7.5.1. Marketing Strategy

16.1.8. BIOTRONIK

16.1.8.1. Overview

16.1.8.2. Product Portfolio

16.1.8.3. Profitability by Market Segments

16.1.8.4. Sales Footprint

16.1.8.5. Strategy Overview

16.1.8.5.1. Marketing Strategy

16.1.9. Medico

16.1.9.1. Overview

16.1.9.2. Product Portfolio

16.1.9.3. Profitability by Market Segments

16.1.9.4. Sales Footprint

16.1.9.5. Strategy Overview

16.1.9.5.1. Marketing Strategy

16.1.10. Qinming Medical

16.1.10.1. Overview

16.1.10.2. Product Portfolio

16.1.10.3. Profitability by Market Segments

16.1.10.4. Sales Footprint

16.1.10.5. Strategy Overview

16.1.10.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2032

Table 2: Global Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 3: Global Market Value (US$ Million) Forecast by Age Group, 2017 to 2032

Table 4: Global Market Value (US$ Million) Forecast by Indication, 2017 to 2032

Table 5: North America Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 6: North America Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 7: North America Market Value (US$ Million) Forecast by Age Group, 2017 to 2032

Table 8: North America Market Value (US$ Million) Forecast by Indication, 2017 to 2032

Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 10: Latin America Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 11: Latin America Market Value (US$ Million) Forecast by Age Group, 2017 to 2032

Table 12: Latin America Market Value (US$ Million) Forecast by Indication, 2017 to 2032

Table 13: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 14: Europe Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 15: Europe Market Value (US$ Million) Forecast by Age Group, 2017 to 2032

Table 16: Europe Market Value (US$ Million) Forecast by Indication, 2017 to 2032

Table 17: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 18: Asia Pacific Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 19: Asia Pacific Market Value (US$ Million) Forecast by Age Group, 2017 to 2032

Table 20: Asia Pacific Market Value (US$ Million) Forecast by Indication, 2017 to 2032

Table 21: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2017 to 2032

Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Product Type, 2017 to 2032

Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Age Group, 2017 to 2032

Table 24: Middle East and Africa Market Value (US$ Million) Forecast by Indication, 2017 to 2032

List of Charts

Figure 1: Global Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 2: Global Market Value (US$ Million) by Age Group, 2022 to 2032

Figure 3: Global Market Value (US$ Million) by Indication, 2022 to 2032

Figure 4: Global Market Value (US$ Million) by Region, 2022 to 2032

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2017 to 2032

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032

Figure 8: Global Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 9: Global Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 10: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 11: Global Market Value (US$ Million) Analysis by Age Group, 2017 to 2032

Figure 12: Global Market Value Share (%) and BPS Analysis by Age Group, 2022 to 2032

Figure 13: Global Market Y-o-Y Growth (%) Projections by Age Group, 2022 to 2032

Figure 14: Global Market Value (US$ Million) Analysis by Indication, 2017 to 2032

Figure 15: Global Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032

Figure 16: Global Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032

Figure 17: Global Market Attractiveness by Product Type, 2022 to 2032

Figure 18: Global Market Attractiveness by Age Group, 2022 to 2032

Figure 19: Global Market Attractiveness by Indication, 2022 to 2032

Figure 20: Global Market Attractiveness by Region, 2022 to 2032

Figure 21: North America Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 22: North America Market Value (US$ Million) by Age Group, 2022 to 2032

Figure 23: North America Market Value (US$ Million) by Indication, 2022 to 2032

Figure 24: North America Market Value (US$ Million) by Country, 2022 to 2032

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 28: North America Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 29: North America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 30: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 31: North America Market Value (US$ Million) Analysis by Age Group, 2017 to 2032

Figure 32: North America Market Value Share (%) and BPS Analysis by Age Group, 2022 to 2032

Figure 33: North America Market Y-o-Y Growth (%) Projections by Age Group, 2022 to 2032

Figure 34: North America Market Value (US$ Million) Analysis by Indication, 2017 to 2032

Figure 35: North America Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032

Figure 36: North America Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032

Figure 37: North America Market Attractiveness by Product Type, 2022 to 2032

Figure 38: North America Market Attractiveness by Age Group, 2022 to 2032

Figure 39: North America Market Attractiveness by Indication, 2022 to 2032

Figure 40: North America Market Attractiveness by Country, 2022 to 2032

Figure 41: Latin America Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 42: Latin America Market Value (US$ Million) by Age Group, 2022 to 2032

Figure 43: Latin America Market Value (US$ Million) by Indication, 2022 to 2032

Figure 44: Latin America Market Value (US$ Million) by Country, 2022 to 2032

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 48: Latin America Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 51: Latin America Market Value (US$ Million) Analysis by Age Group, 2017 to 2032

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Age Group, 2022 to 2032

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Age Group, 2022 to 2032

Figure 54: Latin America Market Value (US$ Million) Analysis by Indication, 2017 to 2032

Figure 55: Latin America Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032

Figure 57: Latin America Market Attractiveness by Product Type, 2022 to 2032

Figure 58: Latin America Market Attractiveness by Age Group, 2022 to 2032

Figure 59: Latin America Market Attractiveness by Indication, 2022 to 2032

Figure 60: Latin America Market Attractiveness by Country, 2022 to 2032

Figure 61: Europe Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 62: Europe Market Value (US$ Million) by Age Group, 2022 to 2032

Figure 63: Europe Market Value (US$ Million) by Indication, 2022 to 2032

Figure 64: Europe Market Value (US$ Million) by Country, 2022 to 2032

Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 68: Europe Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 69: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 71: Europe Market Value (US$ Million) Analysis by Age Group, 2017 to 2032

Figure 72: Europe Market Value Share (%) and BPS Analysis by Age Group, 2022 to 2032

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Age Group, 2022 to 2032

Figure 74: Europe Market Value (US$ Million) Analysis by Indication, 2017 to 2032

Figure 75: Europe Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032

Figure 76: Europe Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032

Figure 77: Europe Market Attractiveness by Product Type, 2022 to 2032

Figure 78: Europe Market Attractiveness by Age Group, 2022 to 2032

Figure 79: Europe Market Attractiveness by Indication, 2022 to 2032

Figure 80: Europe Market Attractiveness by Country, 2022 to 2032

Figure 81: Asia Pacific Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 82: Asia Pacific Market Value (US$ Million) by Age Group, 2022 to 2032

Figure 83: Asia Pacific Market Value (US$ Million) by Indication, 2022 to 2032

Figure 84: Asia Pacific Market Value (US$ Million) by Country, 2022 to 2032

Figure 85: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 88: Asia Pacific Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 91: Asia Pacific Market Value (US$ Million) Analysis by Age Group, 2017 to 2032

Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Age Group, 2022 to 2032

Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Age Group, 2022 to 2032

Figure 94: Asia Pacific Market Value (US$ Million) Analysis by Indication, 2017 to 2032

Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032

Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032

Figure 97: Asia Pacific Market Attractiveness by Product Type, 2022 to 2032

Figure 98: Asia Pacific Market Attractiveness by Age Group, 2022 to 2032

Figure 99: Asia Pacific Market Attractiveness by Indication, 2022 to 2032

Figure 100: Asia Pacific Market Attractiveness by Country, 2022 to 2032

Figure 101: Middle East and Africa Market Value (US$ Million) by Product Type, 2022 to 2032

Figure 102: Middle East and Africa Market Value (US$ Million) by Age Group, 2022 to 2032

Figure 103: Middle East and Africa Market Value (US$ Million) by Indication, 2022 to 2032

Figure 104: Middle East and Africa Market Value (US$ Million) by Country, 2022 to 2032

Figure 105: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2017 to 2032

Figure 106: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 107: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 108: Middle East and Africa Market Value (US$ Million) Analysis by Product Type, 2017 to 2032

Figure 109: Middle East and Africa Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032

Figure 110: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032

Figure 111: Middle East and Africa Market Value (US$ Million) Analysis by Age Group, 2017 to 2032

Figure 112: Middle East and Africa Market Value Share (%) and BPS Analysis by Age Group, 2022 to 2032

Figure 113: Middle East and Africa Market Y-o-Y Growth (%) Projections by Age Group, 2022 to 2032

Figure 114: Middle East and Africa Market Value (US$ Million) Analysis by Indication, 2017 to 2032

Figure 115: Middle East and Africa Market Value Share (%) and BPS Analysis by Indication, 2022 to 2032

Figure 116: Middle East and Africa Market Y-o-Y Growth (%) Projections by Indication, 2022 to 2032

Figure 117: Middle East and Africa Market Attractiveness by Product Type, 2022 to 2032

Figure 118: Middle East and Africa Market Attractiveness by Age Group, 2022 to 2032

Figure 119: Middle East and Africa Market Attractiveness by Indication, 2022 to 2032

Figure 120: Middle East and Africa Market Attractiveness by Country, 2022 to 2032

October 2017

REP-GB-5265

July 2022

306 pages

Healthcare

Sabyasachi Ghosh

Book Now

Clients

Customize This Research

Quick Contact

Chat on Whatsapp + 44 (0) 20 3287 4268 + 44 (0) 20 8123 9659 + 1 347 918 3531 Contact By Email

- Trust FMI -

- Member of -

Greater New York Chamber of Commerce

- Awarded by -

BRONZE STEVIE® Award

20th annual IBAs

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

- Recognized by -

MRI-Safe CRT Devices Market

MRI-Safe CRT Devices Market by Product Type, Age Group, Indication & Region | Forecast 2022 to 2032